<DOC>
	<DOCNO>NCT01127282</DOCNO>
	<brief_summary>Influenza continue inflict important burden health-care system . The 2009 H1N1 influenza virus first appear Mexico United States March April 2009 sweep globe unprecedented speed . The aim study evaluate effect supplement vitamin clinical course patient acute respiratory illness suspect novel H1N1 infection .</brief_summary>
	<brief_title>The Impact Vitamin Clinical Course Cases Infected Novel H1N1 Influenza Virus A</brief_title>
	<detailed_description>Patients acute respiratory illness randomize control vitamin group . The patient complete questionnaire initial symptom score . After 5 day vitamin trial , patient ask symptom telephone survey .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Age &gt; 20 year Acute respiratory illness suspect H1N1 infection Acute febrile respiratory illness ( BT &gt; 37.8 ) throat pain cough nasal congestion Pregnancy Hypersensitivity vitamin A History liver disease renal disease Urinary stone disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>influenza</keyword>
	<keyword>vitamin</keyword>
	<keyword>improvement symptom</keyword>
</DOC>